Discoid Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Discoid Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132 [Phase 4]
Phase 4 clinical trial update indicating that deucravacitinib is being studied in participants with systemic lupus erythematosus (SLE) or di…
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus [Phase 2]
A Phase 2 study of daxdilimab (HZN-7734) in participants with discoid lupus erythematosus has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) [Phase 2]
Phase 2 study evaluating the efficacy and safety of deucravacitinib in active discoid lupus erythematosus and subacute cutaneous lupus eryth…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial evaluating topical ruxolitinib cream for discoid lupus erythematosus has completed, and its results have been poste…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial is studying the efficacy of topical ruxolitinib 1.5% cream in adults with discoid lupus erythematosus; the study is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-01-24FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate manufactured by Ipca Laboratories Limited. The approval updates the p…
-
FDA approval · 2023-03-30FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate filed by Teva Pharmaceuticals USA, Inc., marking an approved change u…
-
FDA approval · 2022-05-03FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp. This action constit…
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. [Phase 2]
A Phase 2 study of delgocitinib cream for discoid lupus erythematosus was terminated, with efficacy and safety results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients [Phase 1, Phase 2]
Phase 1/2 safety study assessing the clinical and immune effects of a PDE-4 inhibitor in discoid lupus erythematosus has completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus [Phase 2]
Phase 2 clinical trial assessing CC-11050 for safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy in discoid and subacute…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus [Phase 2]
Phase 2 trial evaluating intradermal etanercept for remission induction in discoid lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
A completed clinical trial evaluated Fas protein expression in skin biopsies from participants with central centrifugal cicatricial alopecia…
-
CLINICAL_TRIALS withdrawal · 2018-06-28Clinical Trial Update: Cutaneous Lupus Erythematosus and Elidel [NA]
A clinical trial investigating Elidel (pimecrolimus) for cutaneous lupus erythematosus and discoid lupus erythematosus has been withdrawn.
-
FDA approval · 2018-05-01FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for hydroxychloroquine sulfate (generic) from Dr. Reddy's Laboratories Inc. This approval authorizes marketin…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus [Phase 2, Phase 3]
The document reports on a clinical trial evaluating the efficacy of a 595 nm pulsed-dye laser for discoid lupus erythematosus in Phase 2 and…
-
FDA approval · 2017-01-27FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for Plaquenil (hydroxychloroquine sulfate) from Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
A completed study evaluating skin and systemic biomarkers in patients with active cutaneous lupus erythematosus and in healthy volunteers, s…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Pilot Tape Harvesting Study
Biogen completed a pilot tape-harvesting study evaluating tape-stripping methods in subjects with Atopic Dermatitis, Discoid Lupus Erythemat…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions [Phase 2]
Phase 2 trial evaluating the safety and efficacy of Topical R333 in patients with discoid lupus erythematosus and systemic lupus erythematos…
-
FDA approval · 2015-01-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for hydroxychloroquine sulfate submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus [Phase 1]
Amgen conducted a Phase 1 safety study of AMG 811 in subjects with discoid lupus erythematosus, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: A Non-drug Study Profiling Cutaneous Lupus
A completed non-drug clinical trial profiling cutaneous lupus and related lupus forms including cutaneous, systemic, and discoid lupus eryth…
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
This document presents a pooled analysis of belimumab (HGS1006) from the BLISS-52 and BLISS-76 trials in lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of etanercept (Enbrel) for discoid lupus erythematosus. The current trial status i…